Mölnlycke Health Care has signed an agreement to acquire P.G.F. Industry Solutions, the Austrian manufacturer of Granudacyn, a range of solutions for wound cleansing and moisturizing.

Mölnlycke and P.G.F. have worked together for five years on the manufacturing and distribution of Granudacyn, a range of solution and gel products intended for use in the cleansing, irrigation and moisturisation of various wound types. Mölnlycke currently distributes Granudacyn in over 50 countries around the world.

“With an ageing population in combination with increased chronic wounds, such as diabetic foot ulcers or venous leg ulcers, it is our obligation to help ease the burden of wounds on national healthcare regimes” says Zlatko Rihter, CEO of Mölnlycke Health Care. “The acquisition of P.G.F. and its state-of-the-art manufacturing plant, will allow Mölnlycke to aggressively expand our Granudacyn business to improve the lives of even more patients.”

Closure is expected after certain milestones are reached and will be communicated separately.

Photo of Zlatko Rihter: Mölnlycke